Pfizer (PFE) is a publicly traded Healthcare sector company. As of August 30, 2026, PFE trades at $27.94 with a market cap of $159.36B and a P/E ratio of 36.76. PFE moved -0.21% today. Year to date, PFE is +11.04%; over the trailing twelve months it is +13.66%. Its 52-week range spans $20.92 to $28.75. Analyst consensus is buy with an average price target of $28.46. Rallies surfaces PFE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PFE, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $27.94 |
| Market Cap | $159.36B |
| P/E Ratio | 36.76 |
| EPS | $0.76 |
| Dividend Yield | 0.43% |
| 52-Week High | $28.75 |
| 52-Week Low | $20.92 |
| Volume | 7.38M |
| Avg Volume | 0 |
| Revenue (TTM) | $63.70B |
| Net Income | $4.37B |
| Gross Margin | 73.18% |
21 analysts cover PFE: 0 strong buy, 8 buy, 12 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.46.